Assessing the Usefulness of Deferasirox in Modifying Wnt Signalling and Intestinal Tumourigenesis

Project Details

Short titleAssessing the Usefulness of Deferasirox in Modifying Wnt Signalling and Intestinal Tumourigenesis
StatusFinished
Effective start/end date8/02/13 → 31/12/15

Funding

  • Novartis Pharma A.G.